Synbio Tech Inc.
Synbio Tech Inc. manufactures and sells human healthcare products and probiotics for animals. It offers lactobacillus plantarum powder and derivatives of fermented lactic acid bacteria, as well as probiotics for dietary supplements, pets, economic animals, and plant preservation. The company also provides single probiotic strain and multi strain probiotics, and functional strain. Its functional s… Read more
Synbio Tech Inc. (1295) - Total Assets
Latest total assets as of September 2025: NT$2.85 Billion TWD
Based on the latest financial reports, Synbio Tech Inc. (1295) holds total assets worth NT$2.85 Billion TWD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Synbio Tech Inc. - Total Assets Trend (2020–2024)
This chart illustrates how Synbio Tech Inc.’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Synbio Tech Inc. - Asset Composition Analysis
Current Asset Composition (December 2024)
Synbio Tech Inc.'s total assets of NT$2.85 Billion consist of 32.7% current assets and 67.3% non-current assets.
| Asset Category | Amount (TWD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | NT$0.00 | 20.0% |
| Accounts Receivable | NT$112.89 Million | 4.8% |
| Inventory | NT$163.49 Million | 7.0% |
| Property, Plant & Equipment | NT$0.00 | 0.0% |
| Intangible Assets | NT$23.73 Million | 1.0% |
| Goodwill | NT$0.00 | 0.0% |
Asset Composition Trend (2020–2024)
This chart illustrates how Synbio Tech Inc.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Synbio Tech Inc.'s current assets represent 32.7% of total assets in 2024, a decrease from 36.1% in 2020.
- Cash Position: Cash and equivalents constituted 20.0% of total assets in 2024, up from 4.7% in 2020.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 1.0% of total assets, unchanged from 1.0% in 2020.
- Asset Diversification: The largest asset category is inventory at 7.0% of total assets.
Synbio Tech Inc. Competitors by Total Assets
Key competitors of Synbio Tech Inc. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
MedPacto Inc
KQ:235980
|
Korea | ₩51.58 Billion |
|
2H0
F:2H0
|
Germany | €15.27 Million |
|
Shenzhen CAU Technology Co Ltd
SHE:000004
|
China | CN¥260.55 Million |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
|
China | CN¥9.58 Billion |
|
Nanhua Bio Medicine Co Ltd
SHE:000504
|
China | CN¥841.96 Million |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
|
China | CN¥509.14 Million |
|
Chengzhi Shareholding Co Ltd
SHE:000990
|
China | CN¥27.52 Billion |
|
Hualan Biological EngineeringInc
SHE:002007
|
China | CN¥16.27 Billion |
Synbio Tech Inc. - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Synbio Tech Inc. generates 0.42x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Solid ROA - For every $100 in assets, Synbio Tech Inc. generates $7.26 in net profit.
Synbio Tech Inc. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.46 | 2.32 | 2.99 |
| Quick Ratio | 0.97 | 1.77 | 2.29 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | NT$243.66 Million | NT$ 408.07 Million | NT$ 443.78 Million |
Synbio Tech Inc. - Advanced Valuation Insights
This section examines the relationship between Synbio Tech Inc.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.34 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 24.3% |
| Total Assets | NT$2.34 Billion |
| Market Capitalization | $21.14K USD |
Valuation Analysis
Below Book Valuation: The market values Synbio Tech Inc.'s assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Synbio Tech Inc.'s assets grew by 24.3% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Synbio Tech Inc. (2020–2024)
The table below shows the annual total assets of Synbio Tech Inc. from 2020 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | NT$2.34 Billion | +24.30% |
| 2023-12-31 | NT$1.89 Billion | +12.49% |
| 2022-12-31 | NT$1.68 Billion | +9.37% |
| 2021-12-31 | NT$1.53 Billion | +10.67% |
| 2020-12-31 | NT$1.39 Billion | -- |